DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/cwpvk3/global_psoriasis) has announced the addition of the "Global Psoriasis Epidemiology and Patient Flow Analysis - 2015" report to their offering.
This report provides insights into Psoriasis epidemiology, Psoriasis diagnosed patients, and Psoriasis treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Psoriasis derived from epidemiological analysis, percentage of patients diagnosed with Psoriasis, and percentage of patients treated with Psoriasis therapy.
The study helps executives estimate Psoriasis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Psoriasis prevalence, Psoriasis diagnosis rate, and Psoriasis treatment rate for the period 2014 - 2020. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.
Key Topics Covered:
1. Psoriasis: Disease Definition
2. Global Psoriasis Patient Flow
3. Psoriasis Patient Flow in the US
4. Psoriasis Patient Flow in Europe
5. Psoriasis Patient Flow in Germany
6. Psoriasis Patient Flow in France
7. Psoriasis Patient Flow in Spain
8. Psoriasis Patient Flow in Italy
9. Psoriasis Patient Flow in UK
10. Psoriasis Patient Flow in Japan
For more information visit http://www.researchandmarkets.com/research/cwpvk3/global_psoriasis